MSD

Pembrolizumab/Lenvatinib

Biodrugs/ Drugs
Cancer
Pembrolizumab + lenvatinib versus docetaxel for metastatic Non-Small Cell Lung Cancer after platinum doublet chemotherapy and immunotherapy
3Phase III in Spain, 2Phase II, 1Phase I